ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

AGEN Agenus Inc

11.78
3.48 (41.93%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Agenus Inc AGEN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
3.48 41.93% 11.78 23:00:02
Open Price Low Price High Price Close Price Previous Close
8.55 8.45 12.23 11.69 8.30
more quote information »

Recent News

Date Time Source Heading
4/24/202409:00BWBotensilimab/Balstilimab Data in MSS CRC Selected for the..
4/23/202406:30BWAgenus to Provide First Quarter 2024 Financial Report and..
4/12/202406:30BWAgenus Announces Updated Phase 1 Data and Progress on..
4/05/202415:30BWAgenus Announces Reverse Stock Split of Common Stock
3/14/202406:30BWAgenus Reports Fourth Quarter and Full Year 2023 Results
3/06/202406:30BWAgenus Announces Preclinical Data on BMS-986442 (AGEN1777)..
3/05/202415:30BWAgenus Reports Inducement Grants Under Nasdaq Listing Rule..
2/29/202415:50EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2/29/202406:30BWAgenus to Provide Corporate Update and Fourth Quarter & Full..
2/26/202415:24EDGAR2Form DEF 14A - Other definitive proxy statements
2/26/202406:30BWAgenus to Participate in Leerink Partners Global Biopharma..
2/15/202407:02EDGAR2Form PRE 14A - Other preliminary proxy statements
2/15/202407:00EDGAR2Form 8-K - Current report
2/15/202406:02PRNUSGinkgo Bioworks and SaponiQx Awarded MCDC Contract to..
2/14/202407:33EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202406:00EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
2/09/202416:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/31/202407:00EDGAR2Form 8-K - Current report
1/31/202406:30BWAgenus to Participate in Oppenheimer 34th Annual Healthcare..
1/22/202408:59BWBotensilimab/Balstilimab Breakthrough Data Presented at..
1/22/202406:30BWBotensilimab/Balstilimab Breakthrough Data Presented at..
1/05/202415:30BWAgenus Reports Inducement Grants Under Nasdaq Listing Rule..
1/04/202406:30BWAgenus to Participate in B. Riley Healthcare Conference
1/04/202405:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202405:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202405:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/20/202306:30BWBotensilimab/Balstilimab Data in Neoadjuvant Colorectal..
12/11/202306:30BWAgenus to Receive $25 Million Milestone Payment from Bristol..
12/08/202315:15EDGAR2Form 8-K - Current report
11/17/202315:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/09/202315:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202305:30EDGAR2Form 8-K - Current report
11/07/202305:30BWAgenus Reports Third Quarter 2023 Results
10/26/202308:05BWAgenus to Provide Third Quarter 2023 Financial Report and..
10/22/202311:00BWAgenus Unveils New and Updated Botensilimab Data in..
10/21/202303:15BWESMO 2023: Agenus’ Botensilimab/Balstilimab Combination..
10/16/202316:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202306:30BWAgenus Completes Enrollment in Randomized Phase 2 Clinical..
10/06/202315:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/05/202306:30BWAgenus To Host BOT/BAL Program Update at ESMO 2023
10/04/202316:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/04/202316:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/04/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/01/202315:30BWAgenus Reports Inducement Grants Under Nasdaq Listing Rule..
8/31/202316:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/28/202316:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/28/202306:30BWAgenus to Participate in September Investor Conferences
8/23/202307:00EDGAR2Form 8-K - Current report
8/23/202307:00BWAgenus Prioritizes Resources to Accelerate Registration and..
8/09/202307:30BWSaponiQx Announces Breakthrough in Scaling Up of STIMULON™..

Your Recent History

Delayed Upgrade Clock